Brian Dolan @bddol

I write Exits & Outcomes: members-only digital health newsletters + research reports. @ExitsOutcomes Before: Founder, MobiHealthNews (acq'd) Tip? DM for Signal. exitsandoutcomes.com/pricing Massachusetts Joined October 2008

Tweets

5K
Followers

26K
Following

4K
Likes

2K

Brian Dolan @bddol

a year ago

@MLeshchiner @willahmed Yes, same anatomical site as Apple Watch -- so same process for capturing an ECG: "Left-hand fingers to the right wrist or vice versa on a consumer-grade electronic."

0 0 0 61 0

View Details

Brian Dolan @bddol

a year ago

@MLeshchiner @willahmed Whoop has kept it quiet, but I reported on this about a month ago. They already have FDA clearance for ECG capture (unannounced) but I'm guessing FDA is about to clear them for irregular heartbeat notification too. Similar to the 2 FDA clearances Apple Watch secured back in 2018.

1 0 1 116 0

View Details

Nikhil Krishnan @nikillinit

a year ago

can't recommend @bddol 's exit & outcomes publication enough - the databases alone are interesting exitsandoutcomes.com/pricing-for-do…

0 1 8 2K 11

View Details

Brian Dolan @bddol

2 years ago

@nealkhosla Verily's Onduo

1 0 6 169 0

View Details

Brian Dolan @bddol

3 years ago

@OliviaWebbC @ExitsOutcomes This was an interesting move for sure. Just to be clear: This was from a newsletter I wrote back in 2021. Pear has since gone bankrupt.

0 0 0 40 0

View Details

Richard W Mockler @RWMhealth

3 years ago

@rikrenard @ExitsOutcomes Now you’re just straight up stealing all my best client advice. Including that they need to subscribe to @ExitsOutcomes

0 1 3 604 0

View Details

Jacob Brody @jacobbrody

3 years ago

Love @ExitsOutcomes. Among the best healthcare analysts around.

Rik Renard @rikrenard

3 years ago

The SWORD Health Report is yet another banger by @ExitsOutcomes My fav insight: don't try and sell to the big boyz from day 1 Almost never works. Instead target small customers, get their feedback, and use them for your marketing

4 3 33 8K 12

1 1 6 2K 0

View Details

Brian Dolan @bddol

3 years ago

@jacobbrody @ExitsOutcomes Wow. Thanks, Jacob!

0 0 2 29 0

View Details

Brian Dolan @bddol

3 years ago

@rikrenard @ExitsOutcomes Why not both? Sword did manage to sell to large employers too. Pepsi was their first big-name customer. But their small company strategy helped generate momentum.

1 0 1 259 0

View Details

David Van Sickle @dvansickle

3 years ago

Lol wut Via @ExitsOutcomes

4 1 12 3K 1

View Details

Brian Dolan @bddol

3 years ago

@dvansickle @ExitsOutcomes @GregTracy 👀

0 0 0 175 0

View Details

Brian Dolan @bddol

3 years ago

@chrissyfarr Accolade did get a fair bit of press for that but they didn't get into the details of why they lost the customer. Maybe it was a missed opportunity.

Brian Dolan @bddol

4 years ago

Accolade announced today that it lost "a large customer" -- not renewing after 2022 -- Comcast. At one time Comcast accounted for 45 percent of its revenue (fiscal year ending in Feb18) and 35 percent (FY ending Feb19). It was 16 percent of rev in FY2021.

1 4 21 0 2

0 0 1 164 0

View Details

Brian Dolan @bddol

3 years ago

@chrissyfarr Accolade losing Comcast. Did that help them though?

2 0 1 654 0

View Details

Rik Renard @rikrenard

3 years ago

Won't spill all the beans, but you can find the complete report here: exitsandoutcomes.com/the-spring-hea… (don't forget to subscribe to @bddol's blog)

0 1 1 1K 0

View Details

Rik Renard @rikrenard

3 years ago

The Spring Health Report is another banger by @ExitsOutcomes (@bddol). My top three favorite insights: (1) Sell then build Doesn't matter if this is your 1st product or a feature you'll spend significant time on. Make sure people want to pay (extra)

1 3 17 7K 16

View Details

Brian Dolan @bddol

3 years ago

@jryedinak @agingmedia Congrats!

0 0 1 90 0

View Details

Brian Dolan @bddol

3 years ago

@WhelanHealth Yes, but: the Chief Legal Officer at Click, one of the other three buyers, included this line in their bid: "I am not aware of any connection between Click and any insider of the Debtors." Harvest Bio couldn't say the same right? Will those connections cause the judge to nix it?

0 0 1 535 0

View Details

Brian Dolan @bddol

3 years ago

Quite the turn of events: I speculated last week that the mystery buyer of Pear Therapeutics' core assets was its ex-CEO. The purchase agreement reveals this to be true. McCann, under the name Harvest Bio, seems intent on resurrecting Pear using the following assets --> (1/3)

3 15 46 12K 6

View Details

Brian Dolan @bddol

3 years ago

Who is funding McCann's bid to resurrect Pear? A Boston-based, stealthy investor named T.Rx Capital. The fund T.Rx is using to back up McCann's bid was set up Jan 2023. Former Pear exec Michael Langer appears to be a co-founder and managing director of T.Rx too.

0 3 5 1K 1

View Details

Brian Dolan @bddol

3 years ago

The judge presiding over the bankruptcy court proceedings still needs to sign off on the asset sales --so this isn't a done deal yet. And some have already objected to the sale to McCann -- including the federal government and the South Carolina Department of Corrections. (3/3)